CYCLERION THERAPEUTICS, INC. Cash and Restricted Cash
CYCLERION THERAPEUTICS, INC. (CYCN) had Cash and Restricted Cash of $1.39 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.39M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.82M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.24M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.57M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $2.82M S-4/A · filed 2026-07-22 |
| 2025-12-31 | $3.24M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $4.57M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.01M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $3.64M S-4/A · filed 2026-07-22 |
| 2024-12-31 | $3.23M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $2.87M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $4.59M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $5.70M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $7.57M S-4/A · filed 2026-07-22 |
| 2023-09-30 | $9.11M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $5.64M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $7.17M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $13.38M 10-K/A · filed 2025-11-12 |
| 2022-09-30 | $20.41M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $30.32M 10-Q · filed 2023-07-28 |
| 2022-03-31 | $41.13M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $53.96M 10-K · filed 2024-03-05 |
| 2021-09-30 | $62.50M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $70.39M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $45.27M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $58.23M 10-K · filed 2023-03-22 |
| 2020-09-30 | $70.68M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $61.45M 10-Q · filed 2021-07-29 |
| 2020-03-31 | $72.09M 10-Q · filed 2021-04-30 |
| 2019-12-31 | $102.62M 10-K · filed 2022-02-24 |
| 2019-09-30 | $124.76M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $148.76M 10-Q · filed 2020-08-03 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-13 |
| 2018-12-31 | $0.00 10-Q · filed 2020-08-03 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |